Vaccines

intradermal-delivery-of-polio-vaccines-may-dramatically-reduce-the-dose-required-for-vaccination-by-several-folds-thereby-reducing-the-cost-and-increasing-the-affordability

Study compares efficacy of oral, injectable polio vaccines

  • US
  • |
  • News

Singapore: NanoPass Technologies, a pioneer in intradermal vaccine delivery solutions, is collaborating with the US Center of Disease Control and prevention (CDC) in conducting a large phase III trial of polio vaccine in infants in South... Read more

has-the-life-science-industry-learnt-from-previous-flu-outbreaks

How well is the industry prepared to fight H7N9 bird...


  • China
  • |
  • Analysis
  • |
  • By Sheetal Sukhija
  • |
  • 0 Comment

During March 2013, the world woke up to yet another dreaded bird flu attack that infected humans through poultry. Two months... Read more

dr-krishna-ella-chairman-and-managing-director-bharat-biotech-and-member-of-the-scientific-advisory-committee-to-the-prime-minister-india

Everyone thought my $1 vaccine shot idea was crazy...


  • India
  • |
  • Opinion
  • |
  • By Dr Krishna Ella
  • |
  • 0 Comment

My journey as a scientist and a entrepreneur began with my strong interest in science and how it relates to health and wellness.... Read more

flu-drug

New drug to halt flu virus mutation

  • Australia
  • |
  • News
  • |
  • By Nandita Singh
  • |
  • 0 Comment

A better flu drug is on its way. This new class of specific, mechanism-based anti-influenza drug works by preventing the virus from removing... Read more

vaccine-rotavac

Phase III trial of $1 vaccine RotaVac completed

  • India
  • |
  • News
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Pune: The phase III trial of RotaVac, India's first indigenously developed rotavirus vaccine, has been completed and the data is presently... Read more

riboxx-china-national-biotec

China National Biotec, Riboxx ink collaboration

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Germany's Riboxx Pharmaceuticals and China National Biotec Group (CNBG) have initiated a research collaboration to evaluate Riboxxim,... Read more

inviragen-initiates-second-stage-of-phase-ii-trials-of-denvax-dengue-vaccine

Inviragen DENVax dengue vaccine shows promise

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Inviragen initiated second stage of an ongoing phase II, randomized, double-blind, placebo-controlled study of DENVax, the company's... Read more

new-zealand-australian-govt-commit-usd2

NZ, Aus govt commit $2.5 mn for rheumatic vaccine

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The decision by New Zealand and Australian Prime Ministers to investigate potential vaccines against rheumatic fever has been... Read more

more-than-280-000-school-boys-will-get-free-gardasil-vaccine-in-australia

Massive cancer vaccination starts in Aus schools

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian schoolboys have begun receiving the first-of-three vaccinations to protect them against cancers and disease caused... Read more

allied-sales-rise-13-to-3

Allied sales rise 13% to $3.7 mn in H2, 2012

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australia-based Allied Healthcare has marked a stronger sales with revenues up at 13 percent to $3.7 million for six months ending... Read more

tetravalent-dpt-ipv-vaccine-combines-kitasato-daiichi-sankyo-dpt-vaccine-and-sanofi-pasteur-enhanced-inactivated-salk-poliomyelitis-vaccine

Daiichi, Sanofi seeks nod for baby vaccine in Japan

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Kitasato Daiichi Sankyo, a member of the Daiichi Sankyo Group, has applied for approval of its tetravalent combination DPT-IPV... Read more

an-addition-to-the-us-army-arsenal-biodiem-novel-antimicrobial-bdm-i-could-soon-be-to-counter-biological-weapons-source-us-army

Aus vaccine firm helps US army fight bio-terrorism

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian infectious disease therapy and vaccine development company BioDiem's novel antimicrobial (BDM-I) will enter a new... Read more

Special Features

Survey Box

Chinese Bird Flu H7N9

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X